From Liston Street Pulse:
Alnylam Pharmaceuticals, Inc. (ALNY) released its quarterly financial results last Wednesday and reported $.48 earnings per share for the quarter. The consensus estimate was $.39 per share. The company also reported revenue of $9 million for the third quarter. Again, the company beat consensus estimate of $8.64 million. On the […]
The post Alnylam Pharmaceuticals Releases Q3 Results appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015